Stuck for years. Then the whole picture.

The connection no one else made

His serum B12 came back at 1,360 — nearly double the top of range. Every prior reader saw a high, reassuring number and moved on. Minta cross-read it against his genetics — homozygous-slow MTRR — and saw the opposite: a methyl-trap. His body couldn’t convert the B12 it was being flooded with, so it pooled in his blood while his cells starved. The “good” result was actually proof of a functional deficiency — and it quietly rewrote his entire methylation plan.

What the synthesis found

From there, three drivers no single specialist had connected fell into place:

1. An infection no one had named out loud — and the proof was already in his routine blood. Borrelia, Bartonella, Babesia and Mycoplasma showed on dark-field microscopy nobody had ordered. Minta didn’t stop at the image: it corroborated the load from labs everyone already had — ferritin 20 (Bartonella sequesters iron), neutropenia and a high CD57 (the Babesia/Bartonella cytopenia signature). Three “unrelated” abnormalities, one cause.
2. Why his immune system could never close the deal — and what it unlocked. IgA 0.74, IgM 0.29, class-switched memory B-cells at 5.6%: a CVID-spectrum deficiency. A prior immunologist had written “immune dysfunction” and left it there. Minta tied those exact numbers to the failure-to-clear pattern — then to the funding: the same bloodwork qualifies him for IVIG under national health coverage his mom could never have paid for privately.
3. Where the OCD actually came from. His genetics throttle the kynurenine pathway and slow COMT — pulling tryptophan away from serotonin toward quinolinic acid, a neuro-inflammatory byproduct. Not “he has OCD.” A measurable, addressable substrate underneath it.

The methylation pieces no one supplied

His methylation and detox machinery was impaired at multiple steps — slow MTRR, slow COMT on both variants, an NRF2/glutathione block, and a Vitamin-D pathway broken at nearly every gene in the chain. The plan got specific: confirm the functional B12 with an MMA + homocysteine panel, then move him onto the active forms his body can actually use — methylcobalamin and folinic acid in place of the plain B12 and folate he’d been given, titrated to his slow COMT — with targeted glutathione support to open detox. Not more supplements. The right forms, matched to his genetics.

The connection no one else made

Two years of providers had treated his sky-high histamine, his stuck strep, his climbing mycoplasma and his off-the-charts mold as four separate problems. Minta saw one cause sitting under all four — a genetically throttled detox and immune system. His body simply could not clear what every protocol kept trying to kill, so each aggressive round drove die-off faster than he could drain it, and he got worse. Same labs everyone already had. One read nobody had made.

What the synthesis found

Pulled apart, every stuck number had a reason — and they were the same reason:

1. Why the kills kept backfiring. Undermethylation + a CBS sulfur block + low ceruloplasmin throttle drainage at the source — so biomagnetism and antimicrobials produced more die-off than his body could clear. The “regression” after treatment wasn’t the protocol failing; it was working too fast for a body that couldn’t keep up. Even his “freezing in positions” on sulfur supplements was a clue, not a random reaction.
2. Why his histamine never came down. A histadelic biotype, slow histamine-clearing genetics, and histamine-producing gut bacteria — three inputs stacking into one stubborn number no diet alone could move.
3. Why the strep wouldn’t clear and the mycoplasma kept climbing — and the door it opened. Two years of “why won’t these infections resolve,” and no one had screened his immune function. Testing confirmed Specific Antibody Deficiency (SPAD): his body can’t mount a durable response to the bacteria it keeps fighting, so it never finishes the job. SPAD is a recognized diagnosis — which unlocks insurance-covered IVIG, a treatment two years of protocols never put on the table.
4. The mold, in context. Off-the-charts mycotoxins are alarming on their own — but the insight was the stacking: a heavy mold load sitting on a detox system that genetically can’t process it. No one had sequenced the mold against his drainage capacity before going after it.

The methylation pieces no one had matched to him

His methylation machinery was the throttle under everything — an undermethylation pattern on the Yasko panel, a CBS sulfur bottleneck, and low ceruloplasmin. The missing piece wasn’t another supplement; it was the framework and the order. The plan ran Yasko first to open his cycle safely — molybdenum and hydroxy-B12, copper-safe support before any zinc — and only layered in Walsh once his copper status was confirmed. The zinc-heavy Walsh protocols he’d already been put on had been crashing him for exactly the reason no one had checked: you can’t run Walsh before you’ve cleared the Yasko bottleneck.